A Phase 2 basket trial of TOUR-006 for the treatment of additional thyroid eye disease (TED) cohorts
Latest Information Update: 23 Jan 2024
At a glance
- Drugs TOUR-006 (Primary)
- Indications Graves ophthalmopathy
- Focus Therapeutic Use
Most Recent Events
- 29 Jun 2023 New trial record